Introducing The EPHMRA Board
The management of the Association is undertaken by the Board, which derives its authority from the members, and is responsible for fulfilling the objectives of the Association having regard to the decisions taken by the members at the Annual Meeting.
The Board comprises the following members:
- Karsten Trautmann, Board Industry Member, President, Merck KGaA
- Thomas Hein, Board Industry Member, Past President, Thermo Fisher Scientific
- Amr Khalil, Board Agency Member, Ripple International
- Ana Maria Aguirre-Arteta, Board Industry Member, Novartis
- Marcel Slavenburg, Board Agency Member, SKIM
- Stephen Potts, Board Agency Member, Purdie Pascoe
- Xander Raymakers, Board Industry Member, Eli Lilly
- Vijay Chand, Board Industry Member, AstraZeneca, Classification Co-Chair, D&S Chair
- Elizabeth Kehler, Board Agency Member, Adelphi Research
- Paul Warner, Board Industry Member, Vifor Pharma
- Mike Pepp, Board Agency Member, Beyond Blue
- Lauren Halliwell, Board Industry Member, UCB
Members of the Board for 2024 - 2025 are shown on the video below. The term of office is 1 October to 30 September the following year.
https://www.linkedin.com/feed/update/urn:li:activity:7246533694801289216